Clinical Trials
2 trialsNCT03767439 2019-12-18
Nivolumab With Vismodegib in Patients With Basal Cell Nevus Syndrome
Columbia University
Phase 2 Withdrawn
NCT03070691 2017-05-05
Efficacy, Safety and Tolerability of Topically Applied LDE225 Cream (Hedgehog Pathway Inhibitor) in Adult Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS)
Novartis
Phase 2/3 Withdrawn